Dr. G.E. Cramer has defended his PhD thesis ‘Versatile Aspects of Cardiac Troponin Assessment: Innovative Clinical Settings, Coronary Sinus Sampling, and Qualitative Analyses’ on 20th May 2022 at the Radboud University Medical Centre, Nijmegen, the Netherlands.
To mark this glorious milestone, we briefly caught up with Etienne about his research.
Interview with Prof. dr. Elvin Kedhi MD, PhD (interventional cardiologist) | We reached out to some of our favourite investigators to discuss the importance of investigator initiated studies, the common obstacles and latest developments.
We’re pleased to announce the joining of Marta Lantero Rodriguez to our team at Diagram Research.
As Project Manager, Marta is responsible for the coordination of our single centre and multi-centre trials. She’ll support you by creating project plans that incorporates your wishes, complies with the relevant legislation and regulations and stays within budget and timeline.
Patients being monitored remotely, sensors and smartphones transmitting data via Bluetooth, Artificial Intelligence analysing ECGs and providing risk assessments: eHealth is the future.
But what does that mean? Are machines taking over healthcare? Do patients never have to visit the hospital again? And what happens to our data that’s being collected, is it safe?
Ambulance studies are on the rise. Globally, cardiologists, funders and CRO's are coming together to perform pre-hospital phase trials with one main goal: to advance the commencement of treatment, before patients reach the hospital. Because those early minutes are crucial.
We’re talking to Prof. Arnoud van ‘t Hof, M.D., Ph.D., FESC, Head of the Department of Interventional Cardiology in the MUMC, Maastricht and the Zuyderland MC in Heerlen, The Netherlands. He’s been playing a key role in Diagram’s ambulance studies and is the Principal Investigator of the current CELEBRATE trial.
As of 1st November, the VGO became mandatory for drug trials, replacing the current Research Declaration for studies subject to the Medical Research Involving Human Subjects Act (WMO) in the Netherlands.
Dr. J. Thannhauser has defended his PhD thesis titled Technical Innovations in Out-of-Hospital Cardiac Arrest: On the Road to a Smart Defibrillator on 30th September 2021 at the Radboud university medical center, Nijmegen, The Netherlands.
To mark this monumental occasion, we briefly caught up with Jos about his research.
UPDATE ON PREVIOUS ANNOUNCEMENT REGARDING THE NEW SITE SUITABILITY DECLARATION/VGO
As of 1st November, the VGO becomes mandatory for drug trials, replacing the current Research Declaration for studies subject to the Medical Research Involving Human Subjects Act (WMO) in the Netherlands.
